AlexisScherlMDPhD(She/Her)
Pathology • South San Francisco, CAGastrointestinal & Hepatobiliary Pathology, Anatomic Pathology, Clinical Pathology
Scientist - Pathology
Dr. Scherl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 DNA Way
Mail stop 72B
South San Francisco, CA 94080Phone+1 650-225-5576- Is this information wrong?
Summary
- Dr. Alexis Scherl is a pathologist in South San Francisco, CA. She received her medical degree from Albert Einstein College of Medicine and has been in practice 8 years. She specializes in gastrointestinal & hepatobiliary pathology and anatomic pathology and is experienced in biomedical research.
Education & Training
Yale-New Haven HospitalSelective Pathology, 2012 - 2013
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2009 - 2012
Albert Einstein College of MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2013 - 2025
CT State Medical License 2012 - 2014- American Board of Pathology Pathology - Anatomic
Clinical Trials
- A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors Start of enrollment: 2014 Nov 04
- A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors Start of enrollment: 2014 Aug 12
Publications & Presentations
PubMed
- 1 citationsNotch signaling in thyrocytes is essential for adult thyroid function and mammalian homeostasis.Lluc Mosteiro, Thi Thu Thao Nguyen, Simona Hankeova, Daniel Alvarez-Sierra, Mike Reichelt, Shannon M Vandriel, Zijuan Lai, Feroza K Choudhury, Dewakar Sangaraju, Binit...> ;Nature Metabolism. 2023 Dec 1
- 1 citationsAn agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseases.Markus M Xie, Bingbing Dai, Jason A Hackney, Tianhe Sun, Juan Zhang, Janet K Jackman, Surinder Jeet, Ricardo A Irizarry-Caro, Yongyao Fu, Yuxin Liang, Hannah Bender, E...> ;Cell Reports. Medicine. 2023 Aug 15
- 4 citationsIL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models.Jose E Heredia, Clara Sorenson, Sean Flanagan, Victor Nunez, Charles Jones, Angela Martzall, Laurie Leong, Andres Paler Martinez, Alexis Scherl, Hans D Brightbill, Nic...> ;Plos One. 2022 Jan 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
